An Integrated DNA Origami-Based RNA Degrader for Targeted Degradation of Oncogenic Mutant KRAS mRNA
ACS Pharmacology & Translational Science · 13.11.2026 · 9 (11) · 3159-3168
DOI: 10.1021/acsptsci.6c00228 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 02.10.2026. Verfasst von Ying-Fu Li und 6 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, the Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Targeting mutant KRAS represents a critical yet unmet therapeutic challenge across multiple malignancies, as the structural diversity of oncogenic variants and absence of druggable pockets have impeded the development of effective small-molecule inhibitors. Here, we report an integrated RNA degrader system constructed on a six-helix bundle DNA origami (6HB) scaffold that enables efficient and targeted degradation of mutant KRAS mRNA. The system coassembles two modular functional units: an enzyme activity control module comprising an engineered barnase variant and a programmable recognition strand for direct, endogenous-machinery-independent RNA cleavage, and a cell-penetrating module featuring TAT peptides for cytosolic delivery. This integrated architecture eliminates spatiotemporal barriers between delivery and catalysis, achieving robust KRAS mRNA degradation within 16 h while maintaining sufficient specificity for mutant transcripts with minimal impact on wild-type forms. This study demonstrates a proof-of-concept nanoscale platform that integrates targeting, delivery, and catalytic functions for RNA degradation.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- the Natural Science Foundation of Shanghai
Zitieren
APA
Li, Y., Huang, Q., Chen, P., Li, H., Ma, P., Ye, B., & Yin, B. (2026). An Integrated DNA Origami-Based RNA Degrader for Targeted Degradation of Oncogenic Mutant KRAS mRNA. ACS Pharmacology & Translational Science, 9(11), 3159-3168. https://doi.org/10.1021/acsptsci.6c00228
Vancouver
Li Y, Huang Q, Chen P, Li H, Ma P, Ye B, et al. An Integrated DNA Origami-Based RNA Degrader for Targeted Degradation of Oncogenic Mutant KRAS mRNA. ACS Pharmacology & Translational Science. 2026;9(11):3159-3168. doi:10.1021/acsptsci.6c00228
BibTeX
@article{Li2026,
author = {Li, Ying-Fu and Huang, Qing and Chen, Pin-Ru and Li, Hua-Dong and Ma, Pei-Qiang and Ye, Bang-Ce and Yin, Bin-Cheng},
title = {An Integrated DNA Origami-Based RNA Degrader for Targeted Degradation of Oncogenic Mutant KRAS mRNA},
journal = {ACS Pharmacology & Translational Science},
year = {2026},
volume = {9},
number = {11},
pages = {3159--3168},
doi = {10.1021/acsptsci.6c00228}
}
EUVIMED